Upcoming Issue Highlights
Home Subscribe Advertise Sourcebook Free Product Info Home

BergaMet Found to Help Fight Fatty Liver Disease


Two European universities showed that a highly concentrated proprietary extract of the Calabrian bergamot fruit (38 percent citrus bergamot extract, BergaMet/Nathealthsolutions) improves both liver structure and function in patients with nonalcoholic fatty liver disease.

Non-GMO Project

Professor G. Rosano, with the San Raffaelle Pisana Clinic in Rome, said the fruity can help those who suffer from the disease. “Based upon our research, bergamot polyphenol appears to be a clinically useful treatment for patients with fatty liver disease, especially in those with abnormal lipids,” said Rosano.

A separate group of investigators led by Professor F. Andreozzi, with the Polyclinico Umberto I Hospital in Rome, evaluated the BPF/olive leaf extract formulation in 40 patients with fatty liver disease for a period of 60 days. Highly significant improvements in liver function tests were demonstrated in this study, according to the research.

“We are very gratified that two scientific studies conducted in Europe imply that BergaMet may be the best currently available therapy for these alarmingly serious and common conditions,” said Dr. James Ehrlich, an advisor to Nathealthsolutions. “Our initial published results have attracted significant interest from the academic liver community. We are very confident that leading U.S. based liver specialists will initiate new studies to further elucidate the proper roles of BergaMet for patients suffering from fatty liver disorders.”

Affecting 10 percent of children and 20 percent of adults in the U.S., fatty liver disease is a risk factor for heart disease, diabetes and cirrhosis and is projected to become the most common reason for liver transplantations.

For more information, visit www.nathealthsolutions.com.